Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.
Arthritis Res Ther
; 24(1): 13, 2022 01 05.
Article
in En
| MEDLINE
| ID: mdl-34986869
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Scleroderma, Systemic
/
CD28 Antigens
/
Single-Chain Antibodies
/
Inducible T-Cell Co-Stimulator Protein
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Arthritis Res Ther
Journal subject:
REUMATOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Francia
Country of publication:
Reino Unido